United Services Automobile Association Halozyme Therapeutics, Inc. Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$33.32 - $42.1 $335,099 - $423,399	10,057 New	10,057 $371,000
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $73,750 - $109,429	-1,841 Reduced 12.1%	13,371 $760,000
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $5,818 - $7,818	151 Added 1.0%	15,212 $602,000
Q2 2022 Aug 16, 2022	BUY	$37.35 - $48.3 $562,528 - $727,446	15,061 New	15,061 $663,000
Q3 2019 Nov 13, 2019	SELL	$15.2 - $17.69 $695,825 - $809,812	-45,778 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$16.68 - $18.41 $404,123 - $446,037	24,228 Added 112.43%	45,778 $832,000
Q2 2018 Aug 10, 2018	BUY	$16.87 - $20.3 $27,734 - $33,373	1,644 Added 8.26%	21,550 $364,000
Q1 2018 May 14, 2018	BUY	$17.06 - $21.2 $339,596 - $422,007	19,906 New	19,906 $390,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.